PROGNOSIS IN 550 CASES WITH RENAL CELL CARCINOMA

Author:

Satomi Yoshiaki1,Fukuda Momokuni1,Hosaka Masahiko2,Kondo Iichiro3,Yoshimura Sadao4,Fukushima Shuji5,Ida Tokio6,Hirokawa Makoto7,Morita Takashi8,Furuhata Akihiko9,Kumagai Harumi10,Shiozaki Hiroshi11,Ishizuka Eiichi12,Miyai Keikoku13,Senga Yutaka13,Fukuoka Hiroshi14,Sasaki Koichi15,Kodaira Teruo16,Nakahashi Mitsuru17

Affiliation:

1. Department of Urology, Yokosuka Kyosai Hospital

2. Department of Urology, Yokohama City University School of Medicine

3. Department of Urology, Kanagawa Prefectural Cancer Center

4. Department of Urology, Odawara Municipal Hospital

5. Department of Urology, Yokohama Municipal Hospital

6. Department of Urology, Atami National Hospital

7. Department of Urology, Fujisawa Municipal Hospital

8. Department of Urology, Chigasaki Municipal Hospital

9. Department of Urology, Yokosuka National Hospital

10. Department of Urology, Yamato Municipal Hospital

11. Department of Urology, Kawasaki Municipal Ida Hospital

12. Department of Urology, Yokohama Red Cross Hospital

13. Department of Urology, Yokohama City Kohwan Hospital

14. Department of Urology, Yokohama Minami Kyosai Hospital

15. Department of Urology, Yokohama Seamen's Insurance Hospital

16. Department of Urology, Yokosuka Hokubu Kyosai Hospital

17. Department of Urology, Kanagawa Prefectural Ashigarakami Hospital

Publisher

Japanese Urological Association

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3